Работы, на которые ссылается эта работа

Работ: 52

Работа: Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

1. Hallmarks of Cancer: The Next Generation

   Douglas Hanahan, Robert A. Weinberg

   Обзорная статья2011Цитирований: 18

   ABIABI:AkademIndex/openalex/2026.other.003028

2. Tumor-Associated Macrophages: From Mechanisms to Therapy

   Roy Noy, Jeffrey W. Pollard

   Обзорная статья2014Цитирований: 5

   ABIABI:AkademIndex/openalex/2026.other.055340

3. Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy

   Pengfei Zhao, Yonghui Wang, Xuejia Kang +7

   Статья2018Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.056978

4. Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR^T790M‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

   Weimin Yin, Xiaolu Yu, Xuejia Kang +7

   Статья2018Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.056985

5. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

   Hairui Wang, Yisi Tang, Yuefei Fang +6

   Статья2019Цитирований: 4

   ABIABI:AkademIndex/openalex/2026.other.056990

6. Reprogramming Tumor-Associated Macrophages To Reverse EGFR^T790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

   Huige Peng, Binfan Chen, Wei Huang +4

   Статья2017Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.056975

7. Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery

   Hongyue Jin, Yang He, Pengfei Zhao +4

   Статья2018Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.056986

8. Immunotherapy in colorectal cancer: rationale, challenges and potential

   Karuna Ganesh, Zsofia K. Stadler, Andrea Cercek +4

   Обзорная статья2019Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.056989

9. Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

   Binfan Chen, Ang Gao, Bin Tu +7

   Статья2020Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.057000

10. Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity

    Pengfei Zhao, Jiaxin Zhang, Aihua Wu +8

    Статья2020Цитирований: 3

    ABIABI:AkademIndex/openalex/2026.other.057002

11. Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy

    Pengfei Zhao, Weimin Yin, Aihua Wu +8

    Статья2017Цитирований: 3

    ABIABI:AkademIndex/openalex/2026.other.057004

12. Fueling Immunity: Insights into Metabolism and Lymphocyte Function

    Erika L. Pearce, Maya C. Poffenberger, Chih‐Hao Chang +1

    Обзорная статья2013Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.042630

13. Intraperitoneal Therapy for Peritoneal Cancer

    Ze Lu, Jie Wang, M. Guillaume Wientjes +1

    Обзорная статья2010Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056962

14. Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan

    W Chen, J Wang, Lianqun Jia +2

    Статья2016Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056963

15. Lactic acid polarizes macrophages to a tumor-promoting state

    Oscar R. Colegio

    Статья2015Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056964

16. Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

    Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera +11

    Статья2017Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056969

17. Histone Deacetylase Inhibitors as Anticancer Drugs

    Tomáš Eckschlager, Johana Plch, Marie Stiborová +1

    Обзорная статья2017Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056972

18. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

    Daniele V. F. Tauriello, Sergio Palomo‐Ponce, Diana Stork +15

    Статья2018Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056979

19. Roles of Albumin‐Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery

    Pengfei Zhao, Yonghui Wang, Aihua Wu +2

    Обзорная статья2018Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056982

20. Lactoferrin/Hyaluronic acid double-coated lignosulfonate nanoparticles of quinacrine as a controlled release biodegradable nanomedicine targeting pancreatic cancer

    Samar M. Etman, Ossama Y. Abdallah, Radwa A. Mehanna +1

    Статья2020Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056995

21. Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway

    Xinjian Xu, Ji Lv, Fang Guo +10

    Статья2020Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056998

22. Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

    Bin Tu, Meng Zhang, Tuanbing Liu +1

    Обзорная статья2020Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.056999

23. Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy

    Zhidi He, Meng Zhang, Yonghui Wang +6

    Статья2020Цитирований: 2

    ABIABI:AkademIndex/openalex/2026.other.057003

24. Без названия

    ДругоеЦитирований: 1

    ABIABI:AkademIndex/openalex/2026.other.056957

25. Без названия

    ДругоеЦитирований: 1

    ABIABI:AkademIndex/openalex/2026.other.056958